GENEVA, Sept. 16 -- TRUELAB BIOPHARMACEUTICAL CO., LTD. (Room 339, Building C4, Bio-Innovation Park Of Optics Valley, No. 666 Gaoxin Avenue, East Lake Hi-Tech Development ZoneWuhan, Hubei 430073), 帆礼生物技术（武汉）有限公司 (中国湖北省武汉市东湖新技术开发区高新大道666号光谷生物城生物创新园C4西栋339室) filed a patent application (PCT/CN2025/091323) for "ANTIBODY TARGETING TL1A AND USE THEREOF" on Apr 25, 2025. With publication no. WO/2025/185773, the detail...